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Four-hundred-forty-ﬁve husbands of women with invasive cervical carcinoma, 165 of women with in situ cervical cancer, and
717 of control women (age range 19–82 years) were interviewed and a sample of exfoliated cells from the penis obtained in
seven case–control studies conducted by the International Agency for Research on Cancer. The characteristics of human
papillomavirus-positive and human papillomavirus-negative husbands were compared using odds ratios and 95% conﬁdence
intervals. Thirteen per cent of the husbands of control women, 18% of the husbands of women with invasive cervical
carcinoma, and 21% of the husbands of in situ cervical carcinoma women were positive for penile human papillomavirus DNA.
Human papillomavirus 16 was detected in 45 husbands, human papillomavirus 18, 31 or 33 in 19, and human papillomavirus
6/11 in 6, but the majority of human papillomavirus infection (158) was with other or unspeciﬁed human papillomavirus types.
The same human papillomavirus type was seldom identiﬁed in both husband and wife. The strongest variation in penile human
papillomavirus infection was by country, with percentages among the husbands of control women ranging between 3% in
Spain and 39% in Brazil. Having had over 50 lifetime sexual partners, compared with only one, was associated with an odds
ratio of 2.3.
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The importance of the ‘male factor’ (Skegg et al, 1982) in the
aetiology of cervical carcinoma (CC) in women was suggested years
before the identiﬁcation of a sexually-transmitted virus, human
papillomavirus (HPV), as the central cause of these tumours (Du ¨rst
et al, 1983; Mun ˜oz et al, 1992). A close correlation has been
reported between the frequency of cervical and penile carcinoma
in populations (Bosch and Cardis, 1990) and in individual couples
(Smith et al, 1980).
The development of increasingly accurate assays for HPV detec-
tion has brought a clearer understanding of the prevalence of, and
risk factors for, cervical HPV infection in women. Human papillo-
mavirus DNA has been identiﬁed in 99% of CC specimens
(Walboomers et al, 1999). Among women with a normal Pap
smear, between a few per cent and more than 50% of women with
a normal Pap smear harbour HPV DNA in their cervix, depending
upon age and country (Herrero et al, 2000a; Woodman et al,
2001). Conversely, progress in understanding the prevalence and
natural history of genital HPV infection in men has been limited.
Most surveys of penile HPV infection so far have included a few
hundred men at most and have generally been restricted to young
individuals (Hippela ¨inen et al, 1993a,b,c; Baldwin et al, 2001; Kjaer
et al, 2001; Lazcano-Ponce et al, 2001).
The present study examines the prevalence and determinants of
penile HPV infection, according to PCR-based assays, among 1143
husbands of women enrolled in seven case–control studies coordi-
nated by the International Agency for Research on Cancer (IARC).
MATERIALS AND METHODS
The combined data included in these analyses were collected in
ﬁve case-control studies of invasive cervical cancer (ICC) and
two case-control studies of cervical carcinoma in situ (CIS) all
carried out by IARC. The ﬁeldwork was conducted from 1985
through 1993 in Spain (two studies), Colombia (two studies),
Brazil, Thailand, and the Philippines. The detailed methods of
each of these studies have been described elsewhere (Mun ˜oz et
al, 1992; Bosch et al, 1993; Eluf-Neto et al, 1994; Chichareon et
al, 1998; Ngelangel et al, 1998; Castelssague et al, 2002). In brief,
case women had newly diagnosed, histologically conﬁrmed ICC or
CIS. Control women were sampled from the general population in
the two studies of ICC in Spain and Colombia (population-based
studies) and from the same hospitals as the case women for the
other studies (hospital- or clinic-based studies). In all studies,
control women were frequency-matched to case women by age.
All protocols were cleared by the IARC and the local ethical
and research committees.
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www.bjcancer.comThe subjects of the present report are the husbands or current
stable partners of case and control women enrolled in these studies.
Current partners (herein referred to as husbands) were deﬁned as
men having had regular sexual intercourse with the index women
for at least six months, irrespective of whether they were married.
Of the 3790 women (1896 cases and 1894 controls) enrolled in
the original case-control studies, 2800 (1329 cases and 1471
controls) reported having a living husband at study entry. Nine
hundred and eighty-four (74%) husbands of case women and
937 (64%) husbands of control women were interviewed. A total
of 807 (82%) husbands of case women and 717 (77%) husbands
of control women provided penile cytological specimens, of whom
610 (76%) and 533 (74%) yielded a PCR-based valid HPV result,
respectively. Among 610 husbands of case women, 445 were
husbands of women with ICC and 165 of women with CIS. The
median ages of the husbands of control women and of ICC and
CIS cases were, respectively: 45 (range 19–82), 50 (range 22–
79), and 38 (range 22–76) years. The husbands for whom HPV
testing results were available did not differ from those who did
not wish to be included in the study or from those who had an
inadequate penile sample, with respect to various indicators of
sexual behaviour; the mean number of lifetime sexual partners
was in the 11-to-20 category in both participants and non-partici-
pants.
All participating husbands and wives were interviewed separately
using a face-to-face, structured questionnaire administered by
specially trained interviewers of the same gender as the interviewee.
The questionnaire elicited detailed information on demographic
and socio-economic characteristics and a complete lifetime history
of the subject’s sexual experiences including genital hygiene habits.
The lifetime numbers of regular and casual sexual partners and of
partners who were prostitutes were evaluated separately and added
together to obtain the total number of lifetime sexual partners.
Biological samples and HPV DNA detection
After interview, two samples of exfoliated cells were taken from the
penis: one from the distal urethra, using a very thin wet cotton-
tipped swab, and another one from the external surface of the glans
and coronal sulcus, using a standard wet cotton-tipped swab. A
smear was prepared for cytology and the remaining cells were
eluted in phosphate-buffered saline, pelleted and stored at
7208C. Cervical exfoliated cells were also collected from the
women as described for each study (Mun ˜oz et al, 1992; Bosch et
al, 1993; Eluf-Neto et al, 1994; Chichareon et al, 1998; Ngelangel
et al, 1998).
The detailed protocols used for HPV DNA detection by PCR in
the cervical and penile specimens were described elsewhere (Mun ˜oz
et al, 1992; Eluf-Neto et al, 1994; Ngelangel et al, 1998). Brieﬂy,
ampliﬁcation of a fragment of the beta-globin gene served as an
internal control for sufﬁciency of each specimen for ampliﬁcation.
The L1 consensus primers MY09–MY11 (Manos et al, 1989) were
used for the samples collected in the Colombian and Spanish
studies. For samples collected in the remaining studies, GP5/6 or
GP5+/6+ (studies initiated after 1995, women only) general
primers were used (van den Brule et al, 1990; de Roda Husman
et al, 1995). The GP5+/6+ primers were modiﬁed from GP5/6
and provided an increased detection level mainly of less common
HPV types that differ from the common HPV 6/11, 16, 18, 31
and 33 types (de Roda Husman et al, 1995). In the study of
men, GP5/6 PCR products were assessed for HPV-positivity using
a cocktail of HPV-speciﬁc probes and were further genotyped by
hybridization of the PCR products with type-speciﬁc probes for
six HPV types (16, 18, 31, 33, and 6/11) (van den Brule et al,
1990). Samples which were HPV-positive, but did not hybridise
with any of the type-speciﬁc probes, were classiﬁed as ‘other or
unspeciﬁed’. As HPV testing in a proportion of the study women
was performed with GP5+/6+ PCR and included a higher number
of type-speciﬁc probes (33 instead of 6) (Jacobs et al, 1995) than
the assays used for the husbands, a higher proportion of multiple
HPV infections emerged. Thus, in the evaluation of the agreement
in positivity to HPV 16 and HPV 18 types within couples, 22 wives
with multiple HPV infections were classiﬁed as 16 or 18 if such
types were identiﬁed in addition to others.
Statistical analysis
The simple kappa coefﬁcient and corresponding 95% conﬁdence
interval (CI) were used to evaluate the agreement in HPV ﬁndings
between husbands and wives. When the observed agreement
exceeds chance agreement, kappa and CI are positive.
Associations with the presence of penile HPV infection were
evaluated using unconditional multiple logistic regression models
with maximum likelihood estimation of parameter values to obtain
odds ratios (OR) and corresponding 95% CIs (Breslow and Day,
1980). All logistic regression models were adjusted for the
husband’s age, country, and, when indicated, case/control status
of the female partner (i.e., controls, ICC cases, and CIS cases),
and total number of lifetime sexual partners. Tests for linear trend
of the ORs were performed giving an increasing score for each level
of the categorised variable and ﬁtting them in the model as contin-
uous variables.
Heterogeneity among countries in the association between penile
HPV infection and number of sexual partners was tested by
comparing the difference between the 72 log likelihood of the
model estimating a common OR and that estimating a speciﬁc
OR for each group to the chi-square distribution with degrees of
freedom given by the number of groups minus one. The results
for total number of lifetime sexual partners are presented as a
graph, plotting, for each country, the ORs as a black square, whose
size is inversely proportional to the variance of the estimate.
Diamonds are used to plot the summary OR for all studies
together. The centre of the diamond represents the OR and the
extremes the 95% conﬁdence intervals.
All P values were derived from two-sided statistical tests.
RESULTS
Thirteen per cent of the husbands of control women were found to
have penile HPV infection, the most commonly identiﬁed types
being HPV 16 (15 men), followed by 18 and 6/11 (ﬁve each)
(Table 1). Among the husbands of women with ICC and CIS,
17.5% and 21.2%, respectively, had penile HPV infection, most
frequently HPV 16 (23 and seven husbands, respectively). Indepen-
dently from the case/control status of the wife, the majority of
penile infections involved ‘other or unspeciﬁed’ HPV types.
Figure 1 shows the prevalence of penile HPV infection in each
study according to wives’ case/control status. The highest HPV
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Table 1 Prevalence of HPV DNA in penile exfoliated cells among 1143
husbands by HPV type and wives’ case/control status
Control ICC case CIS case
HPV type No (%) No (%) No (%)
Negative 463 (86.9) 367 (82.5) 130 (78.8)
Any type 70 (13.1) 78 (17.5) 35 (21.2)
16 15 (2.8) 23 (5.2) 7 (4.2)
18 5 (0.9) 4 (0.9) 0 (0.0)
31 2 (0.4) 2 (0.5) 2 (1.2)
33 1 (0.2) 2 (0.5) 1 (0.6)
6/11 5 (0.9) 1 (0.2) 0 (0.0)
Other/unspeciﬁed 42 (7.9) 46 (10.3) 25 (15.2)
Total 533 445 165
HPV: human papillomavirus. ICC: Invasive cervical carcinoma. CIS: Carcinoma in situ.
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of case and control women, respectively), followed by the Colom-
bia ICC study (32% and 29%, respectively). Studies from the
Philippines (6% and 5% among the husbands of case and control
women, respectively) and the Spain ICC study (12% and 3%,
respectively) showed the lowest prevalence. The percentage of
penile HPV infection attributable to HPV 16 ranged from less than
2% among husbands of cases and controls in the Philippines and
in the Colombia and Spain ICC studies to 25% among the
husbands of ICC cases in Brazil. Also, HPV 18 was more frequent
in Brazil than elsewhere, while the highest percentage of HPV 6/11
was found among the husbands of controls in the study of CIS in
Colombia (Figure 1).
The agreement in HPV-positivity within 964 couples is shown in
Table 2 for HPV of any type and for HPV types 16 and 18. The agree-
ment in HPV infection of any type was better than chance only
between control couples (kappa test=0.19; 95% CI: 0.07–0.31).
The husbands of HPV-positive control women had a 3.6-fold (95%
CI: 1.7–7.7) increased risk of being HPV-positive themselves,
although not necessarily for the same HPV type. A four-fold
increased risk of positivity for HPV 16 was found among the
husbands of HPV-positive case women (Table 2). HPV 16 was
concurrently found in 1/18 husbands of HPV-16 positive control
women (kappa test=0.03; 95% CI: 70.09–0.14), in 17/179 husbands
of ICC women (kappa test=0.08; 95% CI: 0.04–0.13), and in 4/49
husbands of CIS cases. HPV types 18 (Table 2), 31, 33, or 6/11 were
found rarely in the husbands and never simultaneously in any couple.
The agreement in HPV-positivity was not improved when the
analyses in Table 2 were restricted to 124 couples where both
husbands and wives reported only one sexual partner. HPV types
6/11, 16, 18, 31 and 33 were never found concurrently in monoga-
mous husbands and wives (data not shown).
The risk of penile HPV infection was not associated with age or
tobacco use after adjustment for country, wives’ case/control status,
and total number of lifetime sexual partners (Table 3). Men who
reported secondary education or higher showed an OR of 1.3
(95% CI: 0.9–2.0) compared with those who only attended
primary school or were illiterate. The husbands’ number of regular
sexual partners (OR for 53 vs 1=1.5), and of partners who were
prostitutes (OR for 551 vs 0=1.5) were directly correlated with
the risk of penile HPV infection. For total number of lifetime
sexual partners, the OR was 2.3 (95% CI: 1.1–4.6) for 551 vs 1
partner (Table 3).
Age at ﬁrst sexual intercourse, history of anal intercourse with
women, sexual intercourse with men, and washing genitals regu-
larly after sexual intercourse were unrelated to the risk of penile
HPV infection (Table 4). Men who reported a positive history
for any sexually transmitted disease (STD) had an OR for HPV
infection of 0.9 (95% CI: 0.7–1.3) (Table 4). With respect to speci-
ﬁc STDs, a history of syphilis was reported by 10 HPV-positive and
23 HPV-negative men (OR=1.8; 95% CI: 0.8–4.1). No association
was found for history of gonorrhoea (OR=1.0; 95% CI: 0.6–1.5),
genital herpes (OR=0.8; 95% CI: 0.3–1.8) or genital warts
(OR=0.5; 95% CI: 0.2–1.3).
Regular use of a condom during intercourse with prostitutes was
reported by 37% of husbands, with substantial variation between
countries (1% in Colombia to 86% in Brazil). The OR among
those who never used a condom with prostitutes vs those who
always did was 0.7 (95% CI: 0.3–1.5) (Table 4), with no heteroge-
neity in the ORs between countries. The estimate was unchanged
(OR=0.7; 95% CI: 0.2–3.3) when the analysis was restricted to
the most promiscuous men (511 sexual partners) (data not
shown). Information on condom use with regular partners was
available only for Thailand, the Philippines and Brazil. Seventy-
eight per cent of husbands never used a condom with their regular
partner (OR=0.9; 95% CI: 0.7–1.3).
Figure 2 shows the association between HPV penile infection
and total number of sexual partners by country. The pooled OR
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Figure 1 Prevalence of HPV DNA in penile exfoliated cells among 1143 husbands by wives’ case/control status and study. ICC: Invasive cervical cancer.
CIS: Carcinoma in situ. HPV: Human papillomavirus. Ca: Cases. Co: Controls.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(5), 705–711for 511 vs 410 lifetime sexual partners was 1.8 (95% CI: 1.2–
2.5), but there was heterogeneity between countries. In Colombia
the OR (0.8; 95% CI: 0.4–1.8) was signiﬁcantly lower than the
pooled estimate and no increased OR was found in Brazil
(OR=1.0). When the association with the number of sexual part-
ners who were prostitutes was examined by country and overall
(pooled OR for 511 vs 410 prostitutes=1.4; 95% CI: 1.0–2.0),
again no risk increase emerged for Brazil (OR=1.0) or Colombia
(0.9). Two regular partners or more, compared with one, was asso-
ciated with a pooled OR of 1.4 (95% CI: 1.0–2.0), and in Brazil
and Colombia with an OR of 1.1 (95% CI: 0.5–2.4) and 2.1
(95% CI: 1.1–4.0), respectively (data not shown).
DISCUSSION
We have identiﬁed, by means of PCR-based assays, a prevalence of
penile HPV infection among the husbands of women with or with-
out cervical carcinoma ranging between 3 and 39%, depending
upon country. Thus, the prevalence of HPV DNA in the male geni-
tal tract seems similar to that in the cervix uteri of control women
in the same populations and age groups, if not higher (Mun ˜oz et
al, 1992; Eluf-Neto et al, 1994; Chichareon et al, 1998; Ngelangel
et al, 1998). In agreement with ﬁndings in women without cervical
neoplasia (Herrero et al, 2000b), HPV 16 and 18 types were rela-
tively rare (i.e., less than one third of penile HPV infections)
with the notable exception of Brazilian men, among whom these
types accounted for the majority of penile HPV infections.
At least in our predominantly middle-aged population, the same
type of HPV in both members was identiﬁed in only 2% of more
than 1000 couples. With respect to HPV infections of any type,
there was a moderately increased prevalence in the husbands of
control women who were HPV-positive, but it is noteworthy that
the most promiscuous men tended to be married to the most
promiscuous women (Spearman correlation coefﬁcient between
lifetime sexual partners of wives and husbands=0.16). Ninety-two
per cent of ICC female cases were positive for HPV DNA, yet
penile HPV DNA was found in only 18% of the corresponding
husbands.
A relatively poor correlation in HPV-positivity has also been
reported in previous studies of women and their male sexual part-
ners (Hippelaı ¨nen et al, 1993c; Kyo et al, 1994; Baken et al, 1995;
Strand et al, 1995; Castellsague ￿ et al, 1997). The low agreement in
our study may be partly due to technical reasons, since a relatively
small amount of penile exfoliated cells could be obtained and fewer
HPV types could be speciﬁcally identiﬁed in husbands than wives.
Unlike cervical specimens, most penile ones could not be retested
after new PCR-assays became available, on account of the low cell
yield. However, a subset of male samples from the Philippines that
were originally negative by GP5/6 PCR and could be retested, did
not reveal additional positive ﬁndings by GP5+/6+ PCR (data not
shown).
In some couples, the partner who has been sampled might not
have been the relevant one. Agreement in HPV ﬁndings, however,
was also modest in 124 couples where both the wife and husband
reported only one lifetime sexual partner. The timing of the
sampling of penile and cervical specimens at a relatively old age
is, however, the likeliest explanation for our ﬁndings since spon-
taneous regression of HPV infection is common in men
(Hippelaı ¨nen et al, 1993b; Kjaer et al, 2001) and in women
(e.g., control women in our study) who do not develop cervical
neoplasias (Woodman et al, 2001). Among women with ICC or
CIS, the relevant infection must have occurred many years earlier,
and the relatively low prevalence of penile HPV infection in their
husbands suggests that viral shedding of advanced cervical lesions
is limited.
As in a few previous reports (Hippelaı ¨nen et al, 1993c; Bald-
win et al, 2001), the husbands in our study did not show,
overall or in speciﬁc countries, clear variations in the prevalence
of HPV penile infection by age. We were not able, however, to
exclude the presence of an early peak of HPV infection (30–
40%) in very young men at sexual debut (e.g., among conscripts
in Denmark and Mexico) (Kjaer et al, 2001; Lazcano-Ponce et al,
2001). If the similarity of HPV penile infection across a broad
age range is conﬁrmed in future studies, this may suggest that
spontaneously regressing infections in men are substituted by
new ones over time.
When we looked at the correlates of penile HPV infection, most
of the examined factors seemed to have no inﬂuence, with the
exception of an elevated number of sexual partners. Prostitutes
did not seem to be associated with a higher risk of penile HPV
infection than other women. Furthermore, the association of
HPV penile infection and number of sexual partners was not found
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Table 2 Concordance between HPV-status in 964 couples according to wives’ case/control status
1
Husbands
Wives’ case/control status
Control ICC case CIS case
Wives HPV-neg. NPV-pos. OR (95% CI)
2 HPV-neg. HPV-pos. OR (95% CI)
2 HPV-neg. HPV-pos. OR (95% CI)
2
Any HPV type
Negative 370 45 1 26 5 1 25 9 1
Positive 34 16 3.6 (1.7–7.7) 291 61 1.2 (0.4–3.5) 63 19 1.1 (0.4–3.0)
Kappa test 0.19 0.00 70.02
(95% CI) (0.07, 0.31) (70.02, 0.03) (70.14, 0.10)
HPV 16
Negative 433 14 1 201 3 1 65 2 1
Positive 17 1 1.2 (0.1–12.5) 162 17 4.3 (1.2–16.0) 45 4 3.7 (0.6–24.7)
Kappa test 0.03 0.08 0.06
(95% CI) (70.09, 0.14) (0.04, 0.13) (70.04, 0.16)
HPV 18
Negative 458 5 1 297 4 1 115 0 1
Positive 2 0 0 82 0 0 1 0 1
Kappa test 70.01 70.02 – –
(95% CI) (70.01, 0.00) (0.04, 0.13)
HPV: Human papillomavirus. ICC: Invasive cervical cancer. CIS: Carcinoma in situ. OR: Odds ratio. CI: Conﬁdence interval.
1179 husbands whose wives
had an inadequate HPV test result were excluded.
2Estimates from multiple logistic regression equations adjusted for country and age.
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namely, Brazil and Colombia. In Colombia, although not in Brazil,
the risk of penile HPV infection was found to be directly associated
with the number of regular partners. The greater difﬁculty in eluci-
dating the role of sexual habits in cervical cancer in high-risk
(Mun ˜oz et al, 1996) than in low-risk areas (Bosch et al, 1996)
has already been discussed. Where, for reasons which are still
unclear, the background prevalence of HPV genital infection in a
population is very high, the probability of being infected seems
already elevated at a relatively low level of sexual promiscuity.
In our study, condoms were seldom used as a contraceptive
method with regular sexual partners, but relatively often with pros-
titutes. Use was not associated with a decreased risk of penile HPV
infection. Although a condom confers substantial protection
against several STDs (e.g., gonorrhoea, human immunodeﬁciency
virus, etc.) (Cates and Stone, 1992), a favourable effect against
HPV infection in women or men has not been shown so far (Syrja-
nen et al, 1984). Behavioural (e.g., the difﬁculty of using a condom
consistently in stable relationships) or biological (e.g., extension of
HPV infection beyond the anatomical area covered by a condom)
factors may account for this ﬁnding.
Our study has certain weaknesses but also some strengths.
Unfortunately, we were able to search for relatively few mucosal
HPV types, and no skin type. Viral load could not be assessed,
but, on the basis of rather low hybridisation signals, we had the
impression that viral copy numbers in men are generally lower
than in women.
As three of seven studies were hospital-based, the determined
prevalence of HPV DNA is not necessarily representative of that
in the general male population. Differences in study design (i.e.,
population- vs hospital-based studies, the choice of various
hospital wards, etc.) also obliged us to interpret between-country
comparisons cautiously. The prevalence of penile HPV infection
in our study is, however, positively correlated with cervical
cancer incidence rates in the populations under study (i.e.,
highest in Brazil and Colombia and lower elsewhere) (Parkin
et al, 1997).
Within-country comparisons of HPV-positive and negative men
should not suffer from selection or recall bias, since all interviews
were conducted prior to HPV-testing. Also reassuring is the close
similarity, with respect to various indicators of sexual behaviour,
between the 1143 husbands for whom HPV ﬁndings were available
and the 778 ones who either refused to participate or had inade-
quate penile cell specimens. In order to increase the study power,
husbands of control women and CC case women were pooled
together in some analyses, on account of the similarity in most
ﬁndings. Wives’ case/control status was, however, always adjusted
for and the consistency of ﬁndings was conﬁrmed by stratiﬁed
analyses. For instance, the OR for penile HPV infection was 1.5
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Table 3 Distribution of 1143 husbands of women with and without
cervical carcinoma, ORs and corresponding 95% CIs for penile HPV infec-
tion according to sociodemographic variables, smoking status and lifetime
number of sexual partners
HPV status
1
Positive Negative
No (%) No OR
2 (95% CI)
Age (years)
3
530 12 (16.4) 61 1.0 (0.5–2.2)
30–39
4 45 (15.3) 249 1
40–49 46 (14.7) 268 0.8 (0.5–1.3)
50–59 42 (16.2) 218 0.9 (0.6–1.5)
60 38 (18.8) 164 1.1 (0.6–1.8)
w
2 trend 0.02 P=0.89
Tobacco use
3
Never
4 49 (16.0) 257 1
Current 96 (15.0) 544 1.1 (0.8–1.7)
Former 38 (19.3) 159 1.3 (0.8–2.2)
Education
3
None/Primary
4 111 (17.1) 537 1
Secondary/Higher 71 (14.4) 423 1.3 (0.9–2.0)
Regular sexual partners (no.)
1
4 99 (13.3) 646 1
2 44 (18.7) 191 1.3 (0.9–2.0)
53 40 (24.7) 122 1.5 (1.0–2.4)
w
2 trend 3.87 P=0.05
Partners who were prostitutes (no.)
0
4 53 (12.8) 360 1
1–10 51 (14.3) 307 1.0 (0.6–1.5)
11–50 37 (18.3) 165 1.2 (0.7–1.9)
551 38 (25.0) 114 1.5 (0.9–2.5)
w
2 trend 2.17 P=0.14
Total sexual partners (no.)
1
4 13 (8.4) 141 1
2–10 53 (12.7) 365 1.2 (0.6–2.4)
11–50 66 (17.8) 305 1.7 (0.9–3.3)
551 51 (25.5) 149 2.3 (1.1–4.6)
w
2 trend 8.34 P50.01
OR: Odds ratio. CI: Conﬁdence interval. HPV: Human papillomavirus.
1Subjects with
missing values were not tabulated.
2Estimates from multiple logistic regression equa-
tions adjusted for country, age, and wives’ case/control status, as appropriate.
3As
footnote
2 plus total number of lifetime sexual partners.
4Reference category.
Table 4 Distribution of 1143 husbands of women with and without
cervical carcinoma, ORs and corresponding 95% CIs for penile HPV infec-
tion according to indicators of sexual behaviour
HPV status
1
Positive Negative
No (%) No OR
2 (95% CI)
Age at ﬁrst sexual intercourse (years)
416
3 74 (20.4) 289 1
17–19 63 (15.8) 335 1.0 (0.6–1.5)
520 46 (12.1) 333 0.9 (0.6–1.5)
w
2 trend 0.18 P=0.67
Anal intercourse with women
Never
3 114 (13.4) 734 1
Ever 51 (19.8) 206 1.3 (0.8–1.9)
Sexual intercourse with men
Never
3 171 (16.2) 888 1
Ever 12 (14.5) 71 0.9 (0.4–1.7)
Genital washing after intercourse
Always
3 70 (18.3) 312 1
Sometimes 72 (18.5) 317 1.4 (0.9–2.1)
Never 40 (10.8) 330 0.9 (0.6–1.5)
History of any sexually transmitted disease
Never
3 98 (14.7) 571 1
Ever 85 (18.0) 388 0.9 (0.7–1.3)
Condom use with prostitutes
4
Always
3 54 (20.6) 208 1
Usually/Occasionally 16 (16.0) 84 0.8 (0.4–1.6)
Never 59 (16.3) 303 0.7 (0.3–1.5)
Condom use with regular partners
5
Yes
3 18 (15.3) 100 1
No 74 (17.3) 355 0.9 (0.5–1.7)
OR: Odds ratio. CI: Conﬁdence interval. HPV: Human papillomavirus.
1Subjects with
missing values were not tabulated.
2Estimates from multiple logistic regression equa-
tions adjusted for country, age, and wives’ case/control status.
3Reference category.
4Estimates based on 724 subjects who reported sexual intercourse with prosti-
tutes.
5Data from Thailand, the Philippines and Brazil only.
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women only, and 1.4 for 3 vs 1 regular partners.
The present study is notable for the large number of husbands
and their wives from a wide range of age groups and countries
with different background risks of cervical cancer. Detailed infor-
mation on sexual habits and accurate procedures for the
collection and HPV-testing of penile cell specimens represent addi-
tional strengths. The relatively low within-couple agreement in
HPV-positivity at a single point in time and the steady prevalence
of penile HPV infection with age suggest that the natural history of
HPV may differ between men and women. Despite their difﬁculty,
new cross-sectional and prospective studies in men are warranted
to provide a basis for designing effective HPV prevention strategies.
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